https://www.selleckchem.com/pd-1-pd-l1.html
To investigate clinical features and outcomes of conjunctival melanoma classified by tumour origin. Retrospective review of conjunctival melanoma patients at a single ocular oncology centre between April 18, 1974 and September 9, 2019. Lesions were divided into three tumour origin groups (primary acquired melanosis [PAM], nevus, and de novo) and clinical features and outcomes were compared. There were 629 patients with conjunctival melanoma that arose from PAM (n = 476, 76%), nevus (n = 59, 9%), or de novo (n = 94, 15%). A comparison (PAM vs.
Aimer
Commentaire
Partagez
